吴志明 - 中山大学 - 肿瘤防治中心

个人简介

2011年毕业于上海复旦大学，获得外科医学博士学位，同年8月入职中山大学附属肿瘤医院，作为住院医师接受肿瘤外科专科培训，2013年晋升主治医生；2015年-2016年到美国纽约MSKCC(斯隆凯特琳癌症中心）以及纽约大学Langone医学中心访问学习一年；主要学习泌尿外科最新诊疗技术。回国后成功诊治了不少疑难病例，获得了良好的疗效。教育背景 2008.09 –2011.07　医学博士　复旦大学医学院，泌尿外科学 2006.09 –2008.07　医学硕士　浙江大学医学院，泌尿外科学 2001.09 –2006.07　医学学士　上海同济大学医学院

研究领域

泌尿男生殖系统肿瘤的多学科综合治疗及基础研究，尤其是前列腺癌的早期诊断，靶向穿刺技术，手术治疗以及晚期前列腺癌的综合诊治；肾癌、膀胱癌、睾丸癌、肾上腺肿瘤的临床诊治和转化研究。

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1.Bi X, Wu Z, Han H, Zhou F: Clinical comparison of patients with benign urachal masses versus urachal carcinomas. Chinese journal of cancer 2017, 36(1):2. 2.Xu XL, Ye YL, Wu ZM, He QM, Tan L, Xiao KH, Wu RY, Yu Y, Mai J, Li ZL et al: Overexpression of PTK6 predicts poor prognosis in bladder cancer patients. Journal of Cancer 2017, 8(17):3464-3473. 3.Li Z, Guo S, Wu Z, Han H, Li Z, Wang Y, Chen D, Chen J, Deng C, Qin Z et al: Subclassification of pN3 staging systems for penile cancer: Proposal for modification of the current TNM classification.Urologic oncology 2017, 35(9):543.e541-543.e546. 4.Li Z, Guo S, Wu Z, Han H, Li Z, Wang Y, Chen J, Deng C, Qin Z, Liu Z et al: Proposal for reclassification of N staging system in penile cancer patients, based on number of positive lymph nodes. Cancer Sci 2017. 5. 吴志明,杨芹,李志勇, 等.雌激素相关受体γ和ATP依赖性K+通道Kcnj1在肾脏缺血及再灌注损伤中的作用[J].中华医学杂志,2017,(38):3017-3021. DOI:10.3760/cma.j.issn.0376-2491.2017.38.015. 6.Z. Y. Li1,2,3,*, X. X. Fan4,*, Y. J. Wang1,2,3,*, K. Yao1,2,3, Z. W. Liu1,2,3, W. T. Pan1,2,3, Y. L. Ye1,2,3,P. Yang1,2,3, Y. C. Huang4, Z. M. Wu1,2,3, F. J. Zhou1,2,3 Metastatic renal cell carcinoma: The first report of unilateral fundus hemorrhage induced by Sorafenib. Oncotarget 2016 May 11. Epub 2016 May 11. (correspondence author) 7.Ying Z1, Chen K1, Zheng L2, Wu Y1, Li L1, Wang R1, Long Q1, Yang L1, Guo J3, Yao D3, Li Y1, Bao F3, Xiang G1, Liu J1, Huang Q4, Wu Z5,Hutchins AP1, Pei D1, Liu X6. Transient Activation of Mitoflashes Modulates Nanog at the Early Phase of Somatic Cell Reprogramming. Cell Metab. 2016 Jan 12;23(1):220-6. 8.Wu Z, Huang H, Liu Z, Guo Z, Jiang L, Dong P, Jia G, Chen G. Activation of p21(WAF1/CIP1) by small activating RNA inhibits cell proliferation and induces apoptosis in BEL-7402 hepatoma cell. Zhonghua Yi Xue Za Zhi. 2014 May 27; 94(20):1534-8. 9.Zhi-Ming Wu 1,#, Dai Chun2,#, Huang Ying3,#, et al. Anti-cancer effects of p21WAF1/CIP1 transccriptional induced by dsRNAs in human hepatocellular carcinoma cell lines. Acta Pharmacologica Sina (2011) 32:939-946. 10.Li X, Guo S, Wu Z, Dong P,et al. Surveillance for patients with clinical stage I nonseminomatous testicular germ cell tumors. World J Urol. 2014 Dec [Epub ahead of print] 11.Dong P, Jiang L, Liu J, Wu Z, Guo S, Zhang Z, Zhou F, Liu Z. Induction of paclitaxel resistance by ERα mediated prohibitin mitochondrial-nuclear shuttling. PLoS One. 2013 Dec 23; 8(12):e83519. doi: 10.1371/journal.pone.0083519. eCollection 2013.